top of page
Report.png
Exoskeleton Market

Exoskeleton Market Size, Share, Competitive Landscape and Trend Analysis Report by Mobility, Technology, Extremity and End-User Industry: Global Opportunity and Industry Forecast (2025-2030).

Report ID:

1052

Industry:

Electronics

Published on:

Sept 2025

Exoskeleton Market Summary

Exoskeleton Market had a value of USD 458.25 Mn in 2024 and expected it to hit USD 1,205.26 Mn by 2030, with a CAGR of 17.5 % during the forecast period.

Exoskeleton Industry Trends and Analytical Insights -

  • North America Exoskeleton Market was the largest revenue generating region market in year 2024, with market share accounted for 45.1 %.

  • In 2024, By Mobility, Mobile dominated the Exoskeleton Market, accounted for 62.4% market shares.

  • Leading Key players for Exoskeleton Market in 2024 was Ekso Bionics, Ottobock / SuitX, CYBERDYNE, Inc. and ReWalk Robotics.

Market Size & Forecast

  • Market Size 2024: USD 458.25 Million

  • Projected Market Size 2030: USD 1205.26 Million

  • CAGR (2025-2030): 17.5%

  • North America: Dominated market in 2024

Exoskeleton Market Overview

In 2024, various sectors such as manufacturing floors, rehabilitation clinics & space missions - experienced an increase in demand for exoskeletons, led to an accelerated growth rate of the Exoskeleton Industry in 2024. The rise of this industry was attributed to higher user productivity when using an exoskeleton. The increase in demand means that those industries that utilize exoskeletons was to employ more people and maybe even make additional investments in equipment and training to properly operate the exoskeleton. An example of this was a recent study performed by automakers that included 42 real life operators who participated in an ergonomics experiment; results from the study demonstrated that the use of passive Upper-Limb Exoskeletons were able to improve Upper-Limb Static Posture by an average of 66 seconds compared to baseline performance that was 52.5% increase and improve completion rates of Precision Jobs by approximately 17.5%. The current research in Lower-Limb Exoskeletons is focused on Material Innovation (e.g. Aluminium Alloys, Carbon Fiber, Titanium), Additive Manufacturing (specifically 3D Printed Orthotics) and Actuation Systems (e.g. Electric Motors, Hydraulic/Pneumatic and Compliant Actuators), with Design Trends leaning toward Lighter and More Ergonomic/Customizable solutions. NASA's X1 Exoskeleton, designed for use during Space Missions as an IN-Space Countermeasure, is an excellent example of technological convergence; it generates over 300 Nm of Peak Torque per Joint and has a Minimal yet Adjustable Constitution, designed specifically for Resistance Training and Monitoring Musculoskeletal Activity in a Microgravity Environment.

By 2024, the exoskeleton market was achieved new levels of innovation and usefulness.  Ekso Bionics received Medicare funding for its Indego Personal system and intends to deliver GaitCoach software in early 2024 to improve gait treatment outcomes. Honda's passive industrial exosuit was employed in 24% of global automotive plants, and Cyberdyne's HAL deployments have increased by 31% in Asia, expanding the company's presence in neurorehabilitation. In defense, ReWalk Robotics relaunched as Lifeward and expanded its product line to include rehabilitation and antigravity technology.

In South Korea, KAIST's WalkON Suit F1, a self-positioning, powered exoskeleton, earned news for assisting paraplegics in walking, climbing stairs, and even moving sideways via autonomous locking and environmental sensing. Meanwhile, Fourier Intelligence had unveiled an enhanced GR-2 model for late 2024, which was featured a 63 kg humanoid exoskeleton with 53 degrees of freedom, a detachable battery, and improved task capabilities. The implementation of AI-powered controls in medical and industrial settings significantly improves responsiveness, customization, and safety.

This extensive analysis by Jadhavar Business Intelligence Pvt Ltd provides consumers with a complete and actionable picture of the Global Exoskeleton Market, including market size, share, trends, and growth estimates from 2024 to 2030. It provides a complete overview of important locations and countries by Mobility, Technology, Extremity and End-User Industry. Clients receive comprehensive market dynamics, business tool analysis (PORTER and PESTLE), a Technology roadmap, and regulatory updates. The study also includes country-specific projections, competitive benchmarking, Company profiles, and M&A activity, all of which aid in strategic planning, market entry analysis, and competitor positioning.

Exoskeleton Market Dynamic’s

In 2024, the Exoskeleton Industry was set to advance on the strength of multiple growth drivers, ranging from proven performance gains to increasing user adoption and broader acceptance across key sectors. For example, industrial pilot trials show that workers wearing passive exoskeletal support devices have a 30% reduction in reported lower-back stiffness after just four weeks, while productivity in repeated lifting duties increased by around 18%. Early adopters in rehabilitation clinics reported that patients who used active lower-limb exoskeletons needed 12 fewer therapy hours on average to achieve comparable walking distance thresholds than those who used traditional methods. Wearable sensor advancements and control feedback have resulted in 20% faster response times in gait aid modes, providing users with more real-time flexibility. At the same time, the efficiency of production in the economy was increased because 3D printing reduces the time it takes to manufacture a patient-specific orthotic by approximately 40%. Collectively, this demonstrates how the rapidly evolving industry of exoskeletons has experienced dramatic improvements across the continuum of clinical effectiveness, workplace ergonomics, and speed-to-market — driving market growth through 2024.

The exoskeleton market was forecasted to face a significant challenge in 2024 largely due to their high price of (approx.) USD 100,000 per device, which makes exoskeletons unreachable for most consumers as well as within emerging markets.  Right now, there were approximately 180,000 individuals globally who have sustained a spinal cord injury; however, the FDA has approved only three (3) lower limb exoskeletons (i.e. ReWalk, Ekso and Indego) that were limited to community/institutional use as well. Although 66-78% of people with spinal cord injuries showed improvements in their gait, balance, cardiovascular health and reduction in spasticity following clinical research studies using exoskeletons, there were issues regarding comfort, training-related injury, and low long-term compliance. Similarly, in the industrial world, user trials of the Laevo Flex and Paexo Back exoskeleton devices showed a 38.8% decrease in Iliocostalis muscle activation; however, the development of task-related advantages over a traditional non-exoskeletal device, discomfort (especially in the legs) for the user were the largest barriers to the widespread adoption of the exoskeletal devices. Ultimately, the most significant issues impeding the adoption of exoskeletal devices are cost, regulatory limits, comfort, and ease of use.

In 2024 there was significantly greater awareness from healthcare providers, industrial organizations, and the military of the ability of exoskeletons to assist in mobility, improve workplace safety, and increase productivity. Exoskeletons were utilized in rehabilitation clinics for patients with spinal cord injuries to enhance their gait and balance, as well as to provide services for the wider scope of neuro rehabilitation such as stroke rehabilitation. There was an increasing focus on musculoskeletal disorders, which represented approximately 30% of workplace injuries throughout the world; as such, industries began to explore the use of assistive exoskeletons in order to reduce fatigue and lower their long-term health costs. This accelerated interest helped to create and support additional research by military organizations to improve the endurance of troops and their ability to carry loads, which placed the foundation for using exoskeletons in other fields.

Expert Insights

The Exoskeleton Market in 2024 is transitioning from experimental adoption to practical, outcome-driven deployment, led by strong clinical validation and measurable productivity gains in industrial settings. Mobile and lower-limb exoskeletons dominate due to their versatility in rehabilitation, workplace ergonomics, and defense, while AI-enabled controls, lightweight materials, and additive manufacturing are accelerating usability and customization. North America retains leadership because of regulatory support and funding, but Asia Pacific is emerging rapidly with cost-efficient innovations. Despite high device costs and limited regulatory approvals remaining key barriers, improving reimbursement pathways and proven ROI in injury reduction and therapy efficiency are expected to drive sustained double-digit growth through 2030. 

Exoskeleton Market Segment Analysis

The Exoskeleton Market is segmented into Mobility, Technology, Extremity and End-User Industry.

By Mobility

Based on Mobility segment the Exoskeleton Market is segmented into Mobile and Fixed/Stationary. Mobile has the largest market share of Exoskeleton Market, accounted for 62.4% of the total Mobility segment in 2024. The versatility and broad application of mobile exoskeletons in the Healthcare, Industrial, and Defense sectors define its dominant position. Unlike established stationary devices, exoskeletons enable users to move freely. As such, they facilitate rehabilitation of patients with spinal cord injury, reduce fatigue in Industrial environments, and develop stamina for Military personnel. In addition, manufacturers are developing new Lightweight Materials, Small Actuators, and Longer Lasting Batteries that make Mobile Exoskeletons more Portable and Comfortable for users, making Exoskeletons increasingly attractive to users over Stationary Exoskeletons that are often limited to specialized Clinics or Rehabilitation Facilities only.

By Extremity

Based on Extremity Segment, the Exoskeleton Market is segmented into Upper Body, Lower Body and Full Body. Within the Extremity sector, Lower Body appears the dominated sub segment, accounted for approximately 65.5% of total market share in 2024 for Exoskeleton Market. This dominance arises from its broad usage in spinal cord and stroke therapy, where restoring gait and movement is a primary goal. Its dominance is supported by more regulatory approvals, verified clinical outcomes, and industrial and defense applications, making it the most financially viable and commonly used extremity type when compared to upper and full-body systems.

Exoskeleton Market Region Analysis

North America Exoskeleton Market led the global Market in 2024, accounted for 45.1% of Global Share of Exoskeleton market, Since the significant number of clinical users, focused R&D and finance, and a dense cluster of manufacturers and collaborations in healthcare and industry. The region's supremacy was bolstered by major government financing for rehabilitation technologies, early FDA clearance of medical exoskeletons, and global use in defense programs aimed at enhancing soldier mobility and reducing tiredness. Since the existence of major technology hubs and ongoing innovation in wearable robotics has bolstered North America's global dominance.

By 2024, Europe Exoskeleton Market held 24.5% Shares of the total Exoskeleton Market, with a significant role in rehabilitation networks and industrial ergonomics programs. Asia Pacific accounted for approximately 19.4%, owing to increasing older populations and robot-friendly ecosystems in Japan, South Korea, and China. South America Exoskeleton market accounted approximately 5.8%, while the Middle East and Africa Exoskeleton had a rate of about 5.3%. Although adoption was still in its early stages, it is gaining popularity in specialized clinics and industry pilot programs.

Exoskeleton Market Competitive Analysis

In 2024, the Exoskeleton Market was highly competitive among medical, industrial, and defense companies. Ekso Bionics, ReWalk, and Ottobock/SuitX were the dominant players in rehabilitation based on the strength of their FDA-approved products for clinical use, while Parker Hannifin, Sarcos, and Lockheed Martin had the advantage in the defense and industrial application sectors through developing robust, long-term products. At the same time, emerging companies such as Fourier Intelligence, CYBERDYNE, and DIH Medical gained significant visibility and momentum in Asia and Europe because of their cost-effective, lightweight technologies. Key areas driving competition included regulatory approvals, ergonomic design, and strategic partnerships. In 2024, North America was the dominant market, with the largest revenue share, due to its broad network of producers, high R&D spending, favorable governmental agencies, and extensive adoption of exoskeletons within the medical and defense industries, giving North American companies a competitive advantage for more rapid commercialization and more extensive deployments than any other region.

Exoskeleton Market Scope:

Exoskeleton Market Key Players –

  1. Ekso Bionics

  2. Ottobock / SuitX

  3. CYBERDYNE, Inc.

  4. ReWalk Robotics

  5. Sarcos Technology & Robotics

  6. Parker Hannifin

  7. Hocoma

  8. Bionik Laboratories

  9. DIH Medical

  10. RB3D

  11. Rex Bionics

  12. Lockheed Martin

  13. Fourier Intelligence

  14. Comau

  15. Hyundai Motor Group — Robotics Lab

Frequently Ask Questions – 

  1. Who are the major Key players of Exoskeleton Market?

Ans - The Major Key players of Exoskeleton Market are Ekso Bionics, Ottobock / SuitX, CYBERDYNE, Inc., ReWalk Robotics and Sarcos Technology & Robotics.

  1.  Which Region accounted highest share of the Exoskeleton Market in 2024?

Ans - North America region accounted highest share of the Exoskeleton Market.

  1. What was the market size of Exoskeleton Market in 2024?

Ans - In 2024, market size of the Exoskeleton Market is USD 458.25 Million.

  1. Which Segment is expected to lead the market during forecast period?

Ans - Mobility Segment is the top segment hold the largest share in Exoskeleton Market during forecast period.

  1. What will be the market size of Exoskeleton Market in 2030?

Ans - The market size of Exoskeleton Market in 2030 will be USD 1,205.26 Million.

Report Payment

Single User:
$4199
Spreadsheet:
$2900
Corporate User:
$5500
bottom of page